• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌的未来趋势

Future trends in cervical cancer.

作者信息

Larsen P M, Vetner M, Hansen K, Fey S J

机构信息

Institute of Medical Microbiology, Aarhus University, Denmark.

出版信息

Cancer Lett. 1988 Aug 15;41(2):123-37. doi: 10.1016/0304-3835(88)90109-7.

DOI:10.1016/0304-3835(88)90109-7
PMID:2841018
Abstract

The identification of the close association of certain types of human papillomavirus with the development of cervical cancer should lead to an extensive revision of appropriate health policies. Having taken into account the drawbacks inherent in the existing data (stemming from the use of varying nomenclature, diagnostic methods and reliability, registration and screening practices) it is possible to conclude that the incidence of HPV infections, all premalignant and malignant stages of cervical cancer are, or will soon be, increasing in several countries. This rate of increase is fastest for the younger age groups and is despite the introduction of various forms of screening. These trends therefore indicate an urgent need to adopt policies to avert an unnecessary increase in fatalities due to cervical cancer. It is therefore recommended to: (1) establish a routine diagnostic method which can identify either the type of HPV present or the lesions which are progressing; (2) determine the incidence of HPV infections in the general population; (3) disseminate to medical personnel, teachers, and other members of society existing knowledge concerning the dangers associated with this virus and relevant to preventing its further spread; (4) introduce an effective population screening campaign for all sexually active women, preferably involving a yearly examination at a colposcopy clinic; (5) intensify basic and applied HPV research, especially that which could lead to a deeper understanding of viral transmission and infection, identification of cofactors which promote cervical lesion progression, or to the production of a vaccine.

摘要

某些类型的人乳头瘤病毒与宫颈癌发生之间紧密关联的确定,应促使对适当的卫生政策进行广泛修订。考虑到现有数据存在的缺陷(源于使用不同的命名法、诊断方法及其可靠性、登记和筛查做法),可以得出结论,在一些国家,人乳头瘤病毒感染率以及宫颈癌所有癌前和恶性阶段的发生率正在上升,或很快将上升。尽管已采用各种形式的筛查,但这种上升速度在较年轻年龄组中最快。因此,这些趋势表明迫切需要采取政策,以避免宫颈癌导致的死亡人数不必要地增加。因此建议:(1)建立一种常规诊断方法,能够识别存在的人乳头瘤病毒类型或正在进展的病变;(2)确定普通人群中人乳头瘤病毒感染率;(3)向医务人员、教师和社会其他成员传播有关该病毒相关危险以及预防其进一步传播的现有知识;(4)针对所有性活跃女性开展有效的人群筛查活动,最好每年在阴道镜诊所进行检查;(5)加强基础和应用人乳头瘤病毒研究,特别是那些能够更深入了解病毒传播和感染、识别促进宫颈病变进展的辅助因素或生产疫苗的研究。

相似文献

1
Future trends in cervical cancer.宫颈癌的未来趋势
Cancer Lett. 1988 Aug 15;41(2):123-37. doi: 10.1016/0304-3835(88)90109-7.
2
Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.巴西的人乳头瘤病毒感染与宫颈癌:一项回顾性研究。
Mem Inst Oswaldo Cruz. 1996 Jul-Aug;91(4):433-40. doi: 10.1590/s0074-02761996000400009.
3
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.一个用于评估预防性人乳头瘤病毒16/18型(HPV-16/18)疫苗临床影响的HPV感染和宫颈癌综合自然史模型。
Int J Cancer. 2003 Oct 10;106(6):896-904. doi: 10.1002/ijc.11334.
4
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.人乳头瘤病毒16/18疫苗的预期临床益处和成本效益
J Natl Cancer Inst. 2004 Apr 21;96(8):604-15. doi: 10.1093/jnci/djh104.
5
Effectiveness of preventive human papillomavirus vaccination.预防性人乳头瘤病毒疫苗的有效性。
Int J STD AIDS. 2003 Dec;14(12):787-92. doi: 10.1258/095646203322556084.
6
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.芬兰非特定女性人群中宫颈人乳头瘤病毒感染的患病率、发病率及估计终身风险
Sex Transm Dis. 1990 Jan-Mar;17(1):15-9.
7
Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.冰岛年轻女性参与人乳头瘤病毒疫苗试验的资格与意愿。
Acta Obstet Gynecol Scand. 2003 Apr;82(4):345-50.
8
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.芬兰人乳头瘤病毒16型与宫颈癌的流行病学及疫苗接种的潜在影响:数学建模分析
PLoS Med. 2006 May;3(5):e138. doi: 10.1371/journal.pmed.0030138. Epub 2006 Apr 4.
9
Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.阿根廷宫颈癌高发地区的人乳头瘤病毒宫颈感染及相关风险因素
Infect Dis Obstet Gynecol. 1999;7(5):237-43. doi: 10.1002/(SICI)1098-0997(1999)7:5<237::AID-IDOG6>3.0.CO;2-4.
10
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.人乳头瘤病毒(HPV)预防性疫苗接种:对公共卫生的挑战及对筛查的影响
Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18.

引用本文的文献

1
From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.从人乳头瘤病毒(HPV)到宫颈癌:感染、检测与防治中的社会心理过程
Ann Behav Med. 1996 Fall;18(4):219-28. doi: 10.1007/BF02895283.
2
Genital HPV infection not a local but a regional infection: experience from a female teenage group.生殖器人乳头瘤病毒感染并非局部感染而是区域感染:来自一个女性青少年群体的经验
Genitourin Med. 1993 Feb;69(1):18-22. doi: 10.1136/sti.69.1.18.
3
Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24.
宫颈癌中的杂合性缺失:一个假定的肿瘤抑制基因在染色体11q22 - q24上的亚染色体定位
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6953-7. doi: 10.1073/pnas.91.15.6953.
4
Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.宫颈癌中二号染色体上等位基因的杂合性缺失。
Am J Hum Genet. 1991 Oct;49(4):868-77.